PH

Phreesia, Inc.

PHRHealthcareNASDAQ

Health Information Services

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$480.6M
+14.5% YoY
Net Income
$2.3M
+103.9% YoY
EBITDA
$29.5M
+215.2% YoY
Free Cash Flow
$56.4M

Scan Results

Daily timeframe
2 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 8 RSI OverboughtRSI 71.8, above 70, stock may be overbought
Jul 7 RSI OverboughtRSI 75.1, above 70, stock may be overbought
About Phreesia, Inc.

Headquartered within the healthcare sector, Phreesia, Inc. focuses on Health Information Services services and products. Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company carries a $661.6M market cap, placing it firmly in the small-cap category. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions.

Key stats
Market Cap$661.6M
P/E (TTM)66.94
Fwd P/E6.67
EPS$0.16
Beta0.87
52W Change-58.0%
ROE2.9%
Analysis

The company holds $74.7M in cash, though total debt stands at $92.6M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $56.4M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 2.9% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 1.5% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $280.9M (2023) to $480.6M (2026), reflecting a 71% increase over the period.

At over 50x earnings, PHR carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Phreesia, Inc.'s trajectory.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms